Role of glutathione in the biliary excretion of the arsenical drugs trimelarsan and melarsoprol

Biochemical Pharmacology

Volumn 59, Issue 11, 2000, Pages 1375-1385

  Gregus, Zoltán ^a   Gyurasics, Ágnes ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Arsenic; Biliary excretion; Glucuronidation; Glutathione; Melarsoprol; Trimelarsan

Indexed keywords

ARSENATE SODIUM; GLUTATHIONE; MELARSONYL POTASSIUM; MELARSOPROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG ELIMINATION; DRUG EXCRETION; DRUG GLUCURONIDATION; HEPATOBILIARY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARSENIC; ARSENICALS; BILIARY TRACT; GLUCURONIC ACID; GLUTATHIONE; LIVER; MALE; MELARSOPROL; RATS; RATS, WISTAR; TRYPANOCIDAL AGENTS;

EID: 0034213084     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00263-X     Document Type: Article

References (30)

1. Ishinishi N, Tsuchiya K, Vahter and Fowler BA, Arsenic. In: Handbook on the Toxicology of Metals 2nd Edn, (Eds. Friberg L, Nordberg GF and Vouk V), pp. 43-83. Elsevier Science, New York, 1986.
2. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARα/PML proteins . Blood. 88:1996;1052-1061.
3. Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., Warrel R.P. Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New Engl J Med. 339:1998;1341-1348.
4. Jennings F.W. Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis. Trans R Soc Trop Med Hyg. 84:1990;618-621.
5. König A., Wrazel L., Warrel R.P. Jr, Rivi R., Pandolfi P.P., Jakubowski A., Gabrilove J.L. A Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood. 90:1997;562-570.
6. Rousselot P., Labaume S., Marolleau J.P., Larghero J., Noguera M.H., Brouet J.C., Fermand J.P. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res. 59:1999;1041-1048.
7. Gregus Z., Klaassen C.D. Disposition of metals in rats A comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals . Toxicol Appl Pharmacol. 85:1986;24-38.
8. Gregus Z., Klaassen C.D. Excretion of metal ions Mechanisms aud influencing factors . Berthon G. Handbook on Metal-Ligand Interactions in Biological Fluids. Vol. 1:1995;445-460 Marcel Dekker, New York.
9. Gyurasics Á., Varga F., Gregus Z. Effect of arsenicals on biliary excretion of glutathione and xenobiotics undergoing conjugation with glutathione. Biochem Pharmacol. 41:1991;937-944.
10. Gyurasics Á., Varga F., Gregus Z. Glutathione-dependent biliary excretion of arsenic. Biochem Pharmacol. 42:1991;465-468.
11. Gyurasics Á., Koszorús L., Varga F., Gregus Z. Increased biliary excretion of glutathione is generated by glutathione-dependent hepatobiliary transport of antimony and bismuth. Biochem Pharmacol. 44:1992;1275-1281.
12. Burri C., Baltz T., Giroud C., Doua F., Welker H.A., Brun R. Pharmacokinetic properties of the trypanocidal drug melarsoprol. Chemotherapy. 39:1993;225-234.
13. Nodenot L., Ridet J., Chartrol A., Desmoulins G. Un medicament nouveau contre la maladie du sommeil le MEL W . Med Trop (Marseille). 20:1960;679-698.
14. Harrison S.M., Harris R.W., Bales J.D. Attempt to correlate urine arsenic excretion with clinical course during melarsoprol therapy of patients with Rhodesian trypanosomiasis. Am J Trop Med Hyg. 56:1997;632-636.
15. Plummer L., Smith B.R., Sies H., Bend J.R. Chemical depletion of glutathione in vivo. Methods Enzymol. 77:1981;50-59.
16. Griffith O.W. Depletion of glutathione by inhibition of biosynthesis. Methods Enzymol. 77:1981;59-63.
17. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem. 27:1969;502-522.
18. Ericsson Ö., Schweda E.K., Bronner U., Rombo L., Fridén M., Gustafsson L.L. Determination of melarsoprol in biological fluids by high-performance liquid chromatography and characterisation of two stereoisomers by nuclear magnetic resonance spectroscopy. J Chromatography B Biomed Appl. 690:1997;243-251.
19. Fairlamb A.H., Smith K., Hunter K.J. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei. Mol Biochem Parasitol. 53:1992;223-231.
20. Sedlak J., Lindsay R.H. Estimation of total, protein-bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 25:1968;192-205.
21. Klaassen C.D. Biliary excretion of arsenic in rats, rabbits and dogs. Toxicol Appl Pharmacol. 29:1974;447-457.
22. Delnomdedieu M., Basti M.M., Otvos J.D., Thomas D.J. Reduction and binding of arsenate and dimethylarsinate by glutathione A magnetic resonance study . Chem Biol Interact. 90:1994;139-155.
23. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem Res Toxicol. 10:1997;27-33.
24. Gailer J., Lindner W. On-column formation of arsenic-glutathione species by size-exclusion chromatography in conjunction with arsenic-specific detectors. J Chromatogr Biomed Appl B. 716:1998;83-93.
25. Holeski C.J., Eaton D.L. Effects of glutathione depletion by buthionine sulfoximine (BSO) and diethyl maleate (DEM) on biliary excretion of aflatoxin B1 (AFB) conjugates and covalent AFB-DNA binding. Toxicologist. 6:1986;150.
26. Costa L.G., Murphy S.D. Effect of diethylmaleate and other glutathione depletors on protein synthesis. Biochem Pharmacol. 35:1986;3383-3388.
27. Gregus Z., Stein A.F., Klaassen C.D. Effect of inhibition of γ-glutamyltranspeptidase on biliary and urinary excretion of glutathione-derived thiols and methylmercury. J Pharmacol Exp Ther. 242:1987;27-32.
28. Berger B.J., Fairlamb A.H. Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution. Antimicrob Agents Chemother. 39:1994;1298-1302.
29. Fairlamb A.H., Henderson G.B., Cerami A. Trypanothione is the primary target for arsenical drugs against African trypanosomes. Proc Natl Acad Sci USA. 86:1989;2607-2611.
30. Gregus Z., Gyurasics Á., Koszorús L. Interaction between selenium and group Va-metalloids (arsenic, antimony and bismuth) in the biliary excretion. Environ Toxicol Pharmacol. 5:1998;89-99.